Carlos Pascual

Werfen SA operates as a vitro diagnostics company to provide solutions for hospitals and commercial laboratories for the improvement of patient care. It is in the specialties of hemostasis, acute care diagnostics and autoimmunity. The company was founded in 1966 by Jose Maria Rubiralta Vilaseca and is headquartered in Barcelona, Spain.

Werfen Australia Pty Ltd. is an Australian family-owned company that specializes in diagnostics for hemostasis, acute care, autoimmunity, and transfusion and transplant. The private company's headquarters is located in Europa 21-23, 08908 L'Hospitalet de Llobregat, Spain, and their technology centers are located in Europe and the United States. Werfen Australia is based in Artarmon, AU. The company also has an original equipment manufacturing (OEM) business line where they research, develop, and manufacture customized assays and biomaterials. Founded in 1966 in Spain, the company operates in 30 countries and more than 100 territories through distributors. The CEO is Carlos Pascual.

Werfen NV is a Belgian company that unites its subsidiaries, including Instrumentation Laboratory (IL), Inova Diagnostics (Inova), and Biokit, under one brand name, Werfen. The private company is based in Zaventem, Belgium. The company has completed organizational transitions and adopted a new brand identity, including a new corporate logo. Werfen has been known as Werfen outside of Belgium since 2014. Werfen was founded in 1966, and the CEO is Carlos Pascual.